Evidence map›Paper›PMID 39011896›Full record

ArticleNucleic acids research2024

Adenovirus small E1A directs activation of Alu transcription at YAP/TEAD- and AP-1-bound enhancers through interactions with the EP400 chromatin remodeler.

Simona Cantarella, Marco Vezzoli, Davide Carnevali, Marco Morselli, Nathan R Zemke, Barbara Montanini, Coralie F Daussy, Harald Wodrich, Martin Teichmann, Matteo Pellegrini and 3 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Detection of AdenoviralInternational journal of molecular sciences · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Simona CantarellaDepartment of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy.
Marco VezzoliDepartment of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy.ORCID 0000-0002-0209-3947
Davide CarnevaliDepartment of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy.ORCID 0000-0002-7928-9956
Marco MorselliDepartment of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy.
Nathan R ZemkeMolecular Biology Institute, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Barbara MontaniniDepartment of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy.
Coralie F DaussyBordeaux University, CNRS UMR 5234, Fundamental Microbiology and Pathogenicity, Bordeaux, France.
Harald WodrichBordeaux University, CNRS UMR 5234, Fundamental Microbiology and Pathogenicity, Bordeaux, France.
Martin TeichmannBordeaux University, Inserm U 1312, Bordeaux Institute of Oncology, 33076 Bordeaux, France.ORCID 0000-0002-5257-0510
Matteo PellegriniDepartment of Molecular Cellular and Developmental Biology, University of California Los Angeles, Los Angeles, CA 90095, USA.ORCID 0000-0001-9355-9564
Arnold J BerkMolecular Biology Institute, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Giorgio DieciDepartment of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy.ORCID 0000-0002-8792-3961
Roberto FerrariDepartment of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy.ORCID 0000-0002-0453-0899

Funding

Italian Association for Cancer Research IG2015-16877Professor June Lascelles FundUniversity of Parma
6 · The paper itself

Abstract

Alu retrotransposons, which form the largest family of mobile DNA elements in the human genome, have recently come to attention as a potential source of regulatory novelties, most notably by participating in enhancer function. Even though Alu transcription by RNA polymerase III is subjected to tight epigenetic silencing, their expression has long been known to increase in response to various types of stress, including viral infection. Here we show that, in primary human fibroblasts, adenovirus small e1a triggered derepression of hundreds of individual Alus by promoting TFIIIB recruitment by Alu-bound TFIIIC. Epigenome profiling revealed an e1a-induced decrease of H3K27 acetylation and increase of H3K4 monomethylation at derepressed Alus, making them resemble poised enhancers. The enhancer nature of e1a-targeted Alus was confirmed by the enrichment, in their upstream regions, of the EP300/CBP acetyltransferase, EP400 chromatin remodeler and YAP1 and FOS transcription factors. The physical interaction of e1a with EP400 was critical for Alu derepression, which was abrogated upon EP400 ablation. Our data suggest that e1a targets a subset of enhancer Alus whose transcriptional activation, which requires EP400 and is mediated by the e1a-EP400 interaction, may participate in the manipulation of enhancer activity by adenoviruses.

Indexed as

Adenovirus E1A ProteinsAlu ElementsDNA-Binding ProteinsDNA HelicasesEnhancer Elements, GeneticTranscription Factor AP-1Transcription FactorsAdaptor Proteins, Signal TransducingCell Cycle ProteinsCells, CulturedChromatin Assembly and DisassemblyFibroblastsHistonesHumansNuclear ProteinsPhosphoproteinsAdaptor Proteins, Signal TransducingAdenovirus E1A ProteinsCell Cycle ProteinsDNA-Binding ProteinsDNA HelicasesHistonesNuclear ProteinsPhosphoproteinsSMARCA4 protein, humanTranscription Factor AP-1Transcription FactorsTranscription Factors, TFIIITranscription Factor TFIIICYAP1 protein, humanYAP-Signaling Proteins

Identifiers

PMID39011896
PMCPMC11381368

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.